Mice tumor free and protected from metastases after treatment
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.
The scientists tested a 100-year-old idea called in-situ vaccination. The idea is to put something inside a tumor and disrupt the environment that suppresses the immune system, thus allowing the natural defense system to attack the malignancy.
That something–the hard coating of cowpea mosaic virus–caused no detectible side effects, which are a common problem with traditional therapies and some immunotherapies.
The team’s research is published in the journal Nature Nanotechnology.
“The cowpea virus-based nanoparticles act like a switch that turns on the immune system to recognize and fight against the tumor – as well as to remember it,” said Nicole Steinmetz, an assistant professor of biomedical engineering at Case Western Reserve, appointed by the Case Western Reserve School of Medicine.
“The particles are shockingly potent,” said Steven Fiering, professor of microbiology and immunology at Dartmouth’s Geisel School of Medicine. “They’re easy to make and don’t need to carry antigens, drugs or other immunostimmulatory agents on their surface or inside.”
The professors studied the nanoparticles with Dartmouth’s Pat Lizotte, a molecular and cellular biology PhD student; Mee Rie Sheen, a postdoctoral fellow; and Pakdee Rojanasopondist, an undergraduate student; and Case Western Reserve’s Amy Wen, a biomedical engineering PhD student.
Taking another shot
The immune system’s ability to detect and destroy abnormal cells is thought to prevent many cancers, according to the National Cancer Institute. But when tumors start to develop, they can shut down the system, allowing tumors to grow and spread.
To restart immune defenses, the scientists used the tumor itself as if it were the antigen in a vaccine–that is, the target for antibodies produced by the immune system.
The cowpea virus shell, with its infectious components removed, acts as the adjuvant–a substance that triggers and may enhance or prolong antigen-specific immune responses.
The process and results
The researchers first switched on the immune system in mice to attack B16F10 lung melanoma or skin melanoma, leaving the mice tumor-free. When the treated mice were later injected with B16F10 skin melanoma (to re-challenge the cured mice), four out of five mice were soon cancer free and one had a slow-growing tumor.
The nanoparticles proved effective against ovarian, breast and colon tumor models. Most of the tumors deteriorated from the center and collapsed. The systemic response prevented or attacked metastatic disease, which is the deadliest form of cancer.
“You get benefits against disease you don’t even know is there yet,” Fiering said.
“Because everything we do is local, the side effects are limited,” despite the strength and extent of the immune response, Fiering said. No toxicity was found.
Harsh side effects, such as fatigue, pain, flu-like symptoms and more are common with chemo and radiation therapies and with some immunostimulation drugs.
The researchers are now trying to understand how the virus shell stimulates the immune system.
“It’s not cytotoxic, there’s no RNA involved or lipopolysaccharides that may be used as adjuvants, and it’s not simply an irritant,” Steinmetz said. “We see a specific immune response.”
The Latest on: Immune response against cancer
via Google News
The Latest on:Iimmune response against cancer
- Immune-checkpoint inhibitors highly effective against microsatellite-instability-high cancerson May 26, 2020 at 2:22 pm
(Reuters Health) - Immune-checkpoint inhibitors (ICIs) are highly effective against cancers with defects in DNA mismatch repair proteins, so-called microsatellite-instability-high (MSI-H) cancers, ...
- New clinical trial to test treatment that targets overactive immune response to COVID-19on May 22, 2020 at 12:07 am
For some COVID-19 patients, the body's immune response may be as destructive as the virus that causes the disease.
- Advances in Cancer Vaccineson May 21, 2020 at 7:27 am
Recent advances in immuno-oncology have opened previously unimaginable avenues to produce cancer vaccines. An increasing amount of research shows that immunotherapy could be a powerful weapon in the ...
- INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Modelson May 20, 2020 at 9:19 am
INOVIO (NASDAQ:INO) today announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA vaccine, demonstrating robust neutralizing antibody and T cell immune responses against ...
- Immunotherapy breakthrough recruits more immune cells to fight canceron May 19, 2020 at 11:42 pm
The immune system is one of the most powerful tools we have in the fight against cancer, but sometimes it needs a little extra help. In a new study from the Peter MacCallum Cancer Centre, researchers ...
- Direct control of dendritic cells for tracking and immune modulationon May 18, 2020 at 8:05 am
Dendritic cells (DCs) are one of our bodies' first line of defense against invaders, and are stationed like sentinels at all outer and inner surfaces as well as in most of our organs. When they detect ...
- The Many Faces of the Immune Response to COVID-19: How Cancer Research Is Contributing to a Deeper Understandingon May 15, 2020 at 2:31 pm
During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments.
- Immunai raises $20 million for AI that predicts immune responseon May 14, 2020 at 10:00 am
Immunai, a startup developing AI to predict immune system response, has emerged from stealth with $20 million in seed funding.
- Why does immune response to coronavirus save some, kill others?on May 13, 2020 at 4:37 am
Researchers at TGen, along with City of Hope, seek COVID-19 survivors to study “immune memory” and help unravel the mystery.
- Harvard-designed 'backpacks' turn immune cells into better cancer killerson April 30, 2020 at 5:59 am
Even though macrophages have a reputation for being nonspecific defenders against ... launch an immune response, while the M2 state is linked to healing and tissue regeneration. In cancer ...
via Bing News